Advanced search
Publication Cover
Vascular Health and Risk Management Volume 3, 2007 - Issue 5
Submit an article Journal homepage
81
Views
5
CrossRef citations to date
0
Altmetric
Review

Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE®) in the management of hemophilia A

Amy D ShapiroIndiana Hemophilia and Thrombosis CenterIndianapolis, IN, USACorrespondence[email protected]
Pages 555-565 | Published online: 28 Dec 2022

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Johnny Mahlangu. (2022) An update of the current pharmacotherapeutic armamentarium for hemophilia A. Expert Opinion on Pharmacotherapy 23:1, pages 129-138.
Read now
Elena Santagostino. (2014) A new recombinant factor VIII: from genetics to clinical use. Drug Design, Development and Therapy 8, pages 2507-2515.
Read now
Erik Berntorp, Gerald Spotts, Lisa Patrone & Bruce M Ewenstein. (2014) Advancing personalized care in hemophilia A: ten years’ experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method. Biologics: Targets and Therapy 8, pages 115-127.
Read now
Jerry S Powell. (2009) Recombinant factor VIII in the management of hemophilia A: current use and future promise. Therapeutics and Clinical Risk Management 5, pages 391-402.
Read now
Steven Pipe. (2009) Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia A. Biologics: Targets and Therapy 3, pages 117-125.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.